Mirae Asset Global Etfs Holdings Ltd. Organogenesis Holdings Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,187 shares of ORGO stock, worth $141,277. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,187
Previous 37,381
16.57%
Holding current value
$141,277
Previous $136,000
3.68%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ORGO
# of Institutions
134Shares Held
69.9MCall Options Held
39.7KPut Options Held
0-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Assenagon Asset Management S.A.5.54MShares$25.1 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...